JRSIS Health Care Corporation

JRSSOTCHealthcare● Active

$0.03

+$0.00(+0.00%)

Market Cap$2487200

P/E Ratio—

52W High$0.2

52W Low$0.0058

Avg Volume112K

Open$0.03

Beta0.51

Overview

JRSIS Health Care Corporation (JRSS) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

JRSS · free cash flow · updated Jun 15, 2026

Core FCF metrics

JRSS · FCF · TTM · margin & CAGR

Free cash flow was −$135,550 for FY2025 (fiscal year ending 2025-12-31), up 69.1% year-over-year The FCF margin was -42.3%.

FY2025 Free Cash Flow−$135,550▲ +69.1% YoY

Trailing 12M (TTM)$13,612Trailing 4Q sum · TTM positive vs latest FY negative

FCF Margin-42.3%−$135,550 ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 15, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

JRSS · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$135,551(0M)−$135,550▲ +69.1%-42.3%

FY2024−$438,313(0M)−$438,310▼ 185.1%-33.1%

FY2023$516,724(0M)$515,240▼ 83.0%14.9%

FY2022$3.1M(0M)$3.0M▲ +10.6%—

FY2021$8.2M(6M)$2.7M▲ +15.2%6.2%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

JRSS · P/FCF · FCF yield · FCF per share

JRSIS Health Care Corporation (JRSS) trades at a FCF yield of -0.98% and a price-to-free-cash-flow ratio of N/A. FCF per share stands at $0.00, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

-0.98%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$0.00

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

x-99.7

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

JRSS · cash flow statement · operating / investing / financing

For FY2025, JRSIS Health Care Corporation generated −$0.1M in operating cash flow and spent 0M in capital expenditures, yielding −$0.1M in free cash flow.

Operating Activities

−$0.1M

Cash from core business operations

2025-12-31

Investing Activities

+$0.0M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$0.0M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF (−$0.1M) − |CapEx| (0M) = FCF (−$0.1M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

JRSS vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

JRSIS Health Care CorporationYOU

JRSS

−$135,550+69.1%-42.3%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

JRSIS Health Care Corporation (JRSS) reported free cash flow of −$135,550 for FY2025 (fiscal year ending 2025-12-31), up 69.1% year-over-year. The FCF margin was -42.3%.

Based on available data, JRSIS Health Care Corporation has maintained positive free cash flow for at least 8 fiscal year(s). FCF peaked at $7.9M in FY2019.

JRSIS Health Care Corporation's FCF yield is -0.98% and price-to-FCF ratio is N/A for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

JRSS free cash flow · 8 questions

JRSIS Health Care Corporation free cash flow was −$135,550 for FY2025, up 69.1% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $13,612.

JRSS free cash flowJRSS FCFJRSS FCF 2025JRSS free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · JRSIS Health Care Corporation · JRSIS Health Care Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026